Suppr超能文献

一项评估含迷迭香提取物膳食补充剂对可见面部皮肤质量的安全性和有效性的单中心、双盲、随机、安慰剂对照试验。

A Single-center, Double-blinded, Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of a Dietary Supplement Containing Rosemary Extract on Visible Facial Skin Quality.

作者信息

Draelos Zoe Diana, Gueniche Audrey, Yatskayer Margarita, Nelson Diane B

机构信息

Dr. Draelos is with Dermatology Consulting Services, PLLC, in High Point, North Carolina.

Dr. Gueniche is with L'Oréal Research and Innovation, Development in Chevilly Larue, France.

出版信息

J Clin Aesthet Dermatol. 2025 Mar;18(3):28-33.

Abstract

OBJECTIVE

Glycative stress promotes the accumulation of advanced glycation end products (AGEs), impairing extracellular matrix proteins and accelerating skin aging. Rosemary extract has been shown to deglycate AGE crosslink proteins. The safety of a dietary supplement containing rosemary extract (BioR) and its efficacy on skin quality parameters was evaluated over 12 weeks.

METHODS

The randomized, double-blinded, placebo-controlled trial included female participants, aged 40 to 65 years, with moderate-to-severe skin dullness and roughness/texture, and mild-to-moderate erythema, pore size, and uneven pigmentation based on a six-point grading scale. Subjects were randomized to either BioR (n=52) or placebo ([PLB] n=52). The dosing schedule was as follows: from Weeks 1 to 4, two capsules three times daily; from Weeks 5 to 8, two capsules twice daily; from Weeks 9 to 12, one capsule twice daily. Capsules were taken with food. Investigator assessments occurred at baseline and Weeks 4, 8, and 12. Global skin quality (total sum of scores) and adverse events (AEs) were recorded over 12 weeks.

RESULTS

Mean age, severity and baseline demographics of subjects were similar across groups. Significant mean improvements in BioR versus PLB were observed in skin dullness (=0.04), roughness/texture (=0.001), erythema (=0.05) and pore size (=0.04) at Week 12. No significant differences occurred in uneven pigmentation. Significant mean improvements in global skin quality were demonstrated in BioR versus PLB at Weeks 8 (<0.0001) and 12 (=0.002). One subject (BioR) discontinued at Week 4 due to possibly related, moderate gastrointestinal upset.

CONCLUSION

Following 12 weeks of use, a dietary supplement containing rosemary extract and its natural cofactors led to significant mean visible improvements compared to placebo in skin dullness, roughness/texture, erythema, and pore size, and was well tolerated.

摘要

目的

糖基化应激会促进晚期糖基化终末产物(AGEs)的积累,损害细胞外基质蛋白并加速皮肤衰老。迷迭香提取物已被证明能使AGE交联蛋白去糖基化。对一种含有迷迭香提取物(BioR)的膳食补充剂的安全性及其对皮肤质量参数的功效进行了为期12周的评估。

方法

这项随机、双盲、安慰剂对照试验纳入了年龄在40至65岁之间、具有中度至重度皮肤暗沉以及粗糙/纹理问题、基于六点分级量表存在轻度至中度红斑、毛孔大小和色素沉着不均的女性参与者。受试者被随机分为BioR组(n = 52)或安慰剂组([PLB] n = 52)。给药方案如下:第1至4周,每日三次,每次两粒胶囊;第5至8周,每日两次,每次两粒胶囊;第9至12周,每日两次,每次一粒胶囊。胶囊与食物同服。研究人员在基线以及第4、8和12周进行评估。记录12周内的整体皮肤质量(总分)和不良事件(AE)。

结果

各组受试者的平均年龄、严重程度和基线人口统计学特征相似。在第12周时,观察到BioR组与PLB组相比,在皮肤暗沉(P = 0.04)、粗糙/纹理(P = 0.001)、红斑(P = 0.05)和毛孔大小(P = 0.04)方面有显著的平均改善。色素沉着不均方面未出现显著差异。在第8周(P < 0.0001)和第12周(P = 0.002)时,BioR组与PLB组相比,整体皮肤质量有显著的平均改善。一名受试者(BioR组)在第4周因可能相关的中度胃肠道不适而停药。

结论

使用12周后,与安慰剂相比,一种含有迷迭香提取物及其天然辅助因子的膳食补充剂在皮肤暗沉、粗糙/纹理、红斑和毛孔大小方面导致了显著的平均可见改善,并且耐受性良好。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验